@FiercePharma: That Novartis probe is responding to criminal complaints about lack of disclosure, per Bloomberg: More | Follow @FiercePharma
@EricPFierce: Baxter Intl. investing more into international manufacturing, this time in Puerto Rico but it means 400 fewer jobs. Article | Follow @EricPFierce
> Brazil's Hypermarcas has started 2013 with weaker-than-expected sales but still expects to meet its target for operating profits this year, its CEO said. Report
> Pfizer's ($PFE) Inspra may help improve outcomes in patients who have experienced a particular type of heart attack known as STEMI, a study found. Report
> European regulators say new labeling requirements for drugs deemed risky should take effect in September as originally planned. Report
> Protection against whooping cough weakens a few years after small children receive their final booster vaccination against it. Report
@FierceMedDev: Stryker slapped with FDA warning letter. More | Follow @FierceMedDev
@MarkHFierce: St. Jude Medical is releasing a next-gen stent imaging system in Japan, hoping to propel major interest. Article | Follow @MarkHFierce
@DamianFierce: Cancer Genetics IPO target keeps falling, from $41.9M to $29.3M to $20.1M and, now, just $14.3M. Report | Follow @DamianFierce
> Decision Diagnostics challenges J&J with diabetes test. Story
> Early-stage Alzheimer's blood test on U.K. team's agenda. More
> Crescendo rolls out iPhone app for RA Dx. Item
Biotech News
@FierceBiotech: In case you missed it: Medtronic, Edwards headline this year's ACC news. Roundup | Follow @FierceBiotech
@JohnCFierce: Another high flying cancer drug developer looks like a takeover. Puma turns Pfizer castoff into gold. Report | Follow @JohnCFierce
@RyanMFierce: Shire has acquired Premacure AB for drug against rare eye disease. Release | Follow @RyanMFierce
> Analysts cheer decision to continue Merck's controversial Vytorin study. Article
> Puma Biotech shares roaring up amid M&A meow. Story
> Astellas dumps $390M pact with Ambit on eve of IPO. News
> Omthera files $75M IPO as it blueprints omega-3 drug launch. More
Pharma Manufacturing News
> Marken pushes international expansion with warehouse in China. Item
> Pfizer, Glaxo, others give Interpol money to fight counterfeiters. Report
> Catalent deals target China from 2 directions. Story
Biotech Research News
@EmilyMFierce: The origin of ovarian cancer has evaded scientists, but researchers at Cornell may have found a possible source. More | Follow @EmilyMFierce
> New therapy shows promise in treating inflammatory breast cancer. Report
> Deleting a gene in mice prevents obesity. Article
> Salt may be risk factor for MS, other autoimmune diseases. Story
> Buildup of unwanted proteins may lead to dementia. Item
And Finally... Some experts defend niacin treatment for heart disease despite the results of a new study. Report